Susan Collins actually said...
Even though there are several biosimilars for the best-selling drug in the world, Humira, and they've been on the market in the European Union since 2018, American patients must wait another two years for them to be available here due to the manufacturer's aggressive patent thicket strategy of overlapping and late-filed patents.
03/22/2021